CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 142 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $447,000 | -1.5% | 87,723 | +22.3% | 0.00% | 0.0% |
| Q2 2021 | $454,000 | -14.3% | 71,723 | +4.7% | 0.00% | 0.0% |
| Q1 2021 | $530,000 | -16.1% | 68,533 | -29.0% | 0.00% | -33.3% |
| Q4 2020 | $632,000 | -5.2% | 96,549 | -3.7% | 0.00% | 0.0% |
| Q3 2020 | $667,000 | -16.7% | 100,234 | +4.2% | 0.00% | -25.0% |
| Q2 2020 | $801,000 | +169.7% | 96,164 | +148.7% | 0.00% | +100.0% |
| Q1 2020 | $297,000 | +175.0% | 38,664 | +284.4% | 0.00% | +100.0% |
| Q1 2019 | $108,000 | -65.5% | 10,057 | -51.5% | 0.00% | -50.0% |
| Q4 2018 | $313,000 | -19.3% | 20,737 | -1.0% | 0.00% | 0.0% |
| Q3 2018 | $388,000 | +3.2% | 20,952 | +27.5% | 0.00% | 0.0% |
| Q2 2018 | $376,000 | -17.4% | 16,432 | +2.7% | 0.00% | -33.3% |
| Q1 2018 | $455,000 | +31.5% | 16,002 | -2.4% | 0.00% | +50.0% |
| Q4 2017 | $346,000 | – | 16,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,450,000 | $8,320,500 | 1.17% |
| BVF INC/IL | 6,595,801 | $8,508,583 | 0.23% |
| Bronte Capital Management Pty Ltd. | 925,245 | $1,193,566 | 0.12% |
| Formidable Asset Management, LLC | 318,111 | $410,363 | 0.09% |
| Congress Park Capital LLC | 112,450 | $145,061 | 0.08% |
| Forefront Analytics, LLC | 49,421 | $63,754 | 0.04% |
| Ground Swell Capital, LLC | 10,966 | $14,146 | 0.02% |
| Clearline Capital LP | 196,583 | $253,592 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 81,352 | $104,944 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 2,646,190 | $3,412 | 0.01% |